Leadership

Executive Team Board of Directors

Executive Team

Our team includes some of the world’s most respected oligonucleotide chemists, drug development experts and dedicated patient advocates.

Paul Bolno, MD, MBA

President and Chief Executive Officer, Wave Life Sciences

Michael Panzara, MD, MPH

Chief Medical Officer, Head of Therapeutics Discovery and Development

Chandra Vargeese, PhD

Chief Technology Officer

Kyle Moran

Chief Financial Officer

Jonathan Rosin

Chief Human Resources Officer

Chris Francis, PhD

Senior Vice President, Corporate Development, Head of Emerging Areas

Kenneth Rhodes, PhD

Senior Vice President, Therapeutics Discovery

Linda Rockett, JD

General Counsel

José Juves

Senior Vice President, Corporate Affairs and Patient Advocacy

Board of Directors

Christian Henry, MBA

Chief Executive Officer, Pacific Biosciences

Paul Bolno, MD, MBA

President and Chief Executive Officer, Wave Life Sciences

Mark H. N. Corrigan, MD

Chief Executive Officer, Correvio Pharma Corp.

Peter Kolchinsky, PhD

Managing General Partner, RA Capital Management

Aik Na Tan

Senior Vice-President (Administration), Nanyang Technological University, Singapore

Adrian Rawcliffe

Chief Executive Officer, Adaptimmune Therapeutics plc

Ken Takanashi, MBA, CPA

Executive Vice President, Chief Operating Officer, Shin Nippon Biomedical Laboratories Ltd.

Gregory Verdine, PhD

President and CEO, FOG Pharmaceuticals

Heidi L. Wagner, JD

Senior Vice President, Government Affairs and Policy, Global Blood Therapeutics, Inc.